Latest news
Weekly Recap: XPORT-EC-042 misses PFS endpoint and SENTRY sNDA reports SVR35 - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTAcalabrutinib Yields Frontline PFS Benefit Over Chlorambucil/Rituximab in CLL - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 00:08:17 GMTSelinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 14:37:53 GMTRisvutatug Rezetecan Improves PFS in Phase 3 Osteosarcoma Trial - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 07:00:00 GMTRis-Rez Hits PFS End Point in Phase 3 Osteosarcoma Trial - CancerNetworkCancerNetwork · Tue, 28 Jul 2026 16:08:35 GMT